-+ 0.00%
-+ 0.00%
-+ 0.00%

MAZE THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $50 FROM $34

Reuters·12/18/2025 11:54:31

Please log in to view news